{"id":3431,"date":"2016-09-30T19:18:00","date_gmt":"2016-09-30T19:18:00","guid":{"rendered":"http:\/\/blogs.sld.cu\/oserranob\/?p=3431"},"modified":"2016-09-30T19:43:18","modified_gmt":"2016-09-30T19:43:18","slug":"estado-de-farmacogenetica-en-centroamerica-y-el-caribe","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2016\/09\/30\/estado-de-farmacogenetica-en-centroamerica-y-el-caribe\/","title":{"rendered":"Estado de farmacogen\u00e9tica en Centroam\u00e9rica y el Caribe"},"content":{"rendered":"<p style=\"text-align: justify\"><a href=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2016\/09\/2016-09-30-PGx.jpg\"><img loading=\"lazy\" class=\"alignleft size-full wp-image-3455\" style=\"border-width: 1px;margin: 5px\" src=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2016\/09\/2016-09-30-PGx.jpg\" alt=\"2016 09 30 PGx\" width=\"85\" height=\"71\" \/><\/a>Las investigaciones sobre farmacogen\u00e9tica en Am\u00e9rica Central y el Caribe son escasas o nulas, limitadas a la oncolog\u00eda y dirigidas a los biomarcadores <a title=\"Informaci\u00f3n sobre el gen en Gene\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/1565\" target=\"_blank\">CYP2D6<\/a> y <a title=\"Informaci\u00f3n sobre el gen en Gene\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/3105\" target=\"_blank\">HLA-A<\/a>\/<a title=\"Informaci\u00f3n sobre el gen en Gene\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/gene\/3106\" target=\"_blank\">B<\/a>. Tales resultados son divulgados en C\u00e9spedes-Garro C, Naranjo MG, Rodrigues-Soares F, LLerena A, Duconge J, Montan\u00e9-Jaime LK, <em>et al<\/em>. <a title=\"Resumen en ingl\u00e9s, con acceso a PDF\" href=\"http:\/\/www.futuremedicine.com\/doi\/abs\/10.2217\/pgs-2016-0053?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%3dpubmed\" target=\"_blank\">Pharmacogenetic research activity in Central America and the Caribbean: a systematic review<\/a>. Pharmacogenomics. 2016 Sep 16.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Las investigaciones sobre farmacogen\u00e9tica en Am\u00e9rica Central y el Caribe son escasas o nulas, limitadas a la oncolog\u00eda y dirigidas a los biomarcadores CYP2D6 y HLA-A\/B. Tales resultados son divulgados en C\u00e9spedes-Garro C, Naranjo MG, Rodrigues-Soares F, LLerena A, Duconge J, Montan\u00e9-Jaime LK, et al. Pharmacogenetic research activity in Central America and the Caribbean: a [&hellip;]<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[19,31],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/3431"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=3431"}],"version-history":[{"count":3,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/3431\/revisions"}],"predecessor-version":[{"id":3456,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/3431\/revisions\/3456"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=3431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=3431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=3431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}